Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia
- 26 June 2018
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (10) , e27300
Abstract
Background: Treatment‐related osteonecrosis (ON) is a serious complication of treatment of acute lymphoblastic leukemia (ALL).Procedure: This study included 1,489 patients with ALL, aged 1–45 years, treated according to the Nordic Society of Paediatric Haematology and Oncology ALL2008 protocol, using alternate‐week dexamethasone during delayed intensification, with prospective registration of symptomatic ON. We aimed at comparing risk factors, timing, and clinical characteristics of ON in children and young adults.Results: ON was diagnosed in 67 patients, yielding a 5‐year cumulative incidence of 6.3%, but 28% in female adolescents. Median age at ALL diagnosis was 12.1 years and 14.9 years for females and males, respectively. At ON diagnosis, 59 patients had bone pain (91%) and 30 (46%) had multiple‐joint involvement. The median interval between ALL and ON diagnosis was significantly shorter in children aged 1.0–9.9 years (0.7 years [range: 0.2–2.1]) compared with adolescents (1.8 years [range: 0.3–3.7, P < 0.001]) and adults (2.1 years [range: 0.4–5.3, P = 0.001]). Female sex was a risk factor in adolescent patients (hazard ratio [HR] = 2.1, 95% confidence interval [CI]: 1.1–4.2) but not in children aged 1.1–9.9 years (HR = 2.4, 95% CI: 0.9–6.2, P = 0.08) or adults aged 19–45 years (HR = 1.1, 95% CI: 0.3–4.0). Age above 10 years at ALL diagnosis (odds ratio [OR] = 3.7, P = 0.026) and multiple joints affected at ON diagnosis (OR = 3.4, P = 0.027) were risk factors for developing severe ON.Conclusion: We provide a detailed phenotype of patients with ALL with symptomatic ON, including description of risk factors and timing of ON across age groups. This awareness is essential in exploring measures to prevent development of ON.Keywords
Funding Information
- Børnecancerfonden
- Barncancerfonden
- Dagmar Marshalls Fond
- Dansk Kræftforsknings Fond
- Ingeniør Otto Christensens Fond
- Axel Muusfeldts Fond
This publication has 45 references indexed in Scilit:
- Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthoodHaematologica, 2013
- Adult acute lymphoblastic leukaemia in Denmark. A national population‐based retrospective study on acute lymphoblastic leukaemia in Denmark 1998–2008British Journal of Haematology, 2012
- Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaBlood, 2011
- Bone microstructure at the distal tibia provides a strength advantage to males in late puberty: An HR-pQCT studyJournal of Bone and Mineral Research, 2010
- Management of glucocorticoid-induced osteoporosisNature Reviews Rheumatology, 2010
- Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL)Pediatric Blood & Cancer, 2010
- Sex Steroids, Growth Hormone, Leptin and the Pubertal Growth Spurt2009
- High Body Mass Index Increases the Risk for Osteonecrosis in Children With Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2007
- Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in SwedenCancer, 2006
- Variations in pattern of pubertal changes in girls.Archives of Disease in Childhood, 1969